Longevity Medicine · Clinical Wellness
When Cold Becomes Medicine: Whole-Body Cryotherapy and the Chronic Fatigue Puzzle
Far from a wellness trend, whole-body cryotherapy is emerging as a physiologically grounded intervention for one of medicine’s most elusive conditions — and what it reveals about biological aging may surprise you.
Carolina Hernández Peratta
Clinical Biochemist · Founder & Academic Director, Master’s in Longevity Medicine & Age Management, University of Barcelona · CEO, Longevity Zone SL · Co-founder, LifeR Longevity Clinic · Founder, Dopamina · Scientific Advisor, HAUS Healthy Building · Member, Royal Academy of Medical and Health Sciences of Catalonia
The condition no one fully understands
Cryotherapy for chronic fatigue is not about treating ordinary tiredness. Chronic Fatigue Syndrome — also known as Myalgic Encephalomyelitis (ME/CFS) — is not simply tiredness that won’t go away. It is a systemic dysregulation that simultaneously disrupts the autonomic nervous system, cardiovascular function, the HPA axis, cognitive performance, and muscular metabolism. Its global prevalence ranges from 0.4% to 2.5% of the population, with numbers rising sharply in the post-COVID era.
What makes ME/CFS particularly challenging — and particularly interesting from a longevity medicine perspective — is that it is measurable. Heart rate variability, aortic stiffness, baroreceptor sensitivity, cognitive processing speed: these are objective biomarkers that allow clinicians to track both baseline status and response to treatment. This is not a subjective condition. It is a homeostatic failure with biological fingerprints.
ME/CFS is not a disease of fatigue — it is a disease of homeostatic dysregulation. Understanding it this way changes everything about how we approach it therapeutically.
Enter the cold chamber
Whole-body cryotherapy (WBC) was developed in Japan in the late 1970s and gained traction across Europe through rehabilitation and rheumatology medicine. The protocol is deceptively simple: two to three minutes of exposure to temperatures between −110°C and −160°C in a dry cryogenic chamber. No sustained muscular effort. No aerobic load. Just a precisely dosed thermal shock.
That brief exposure triggers a cascade of physiological responses that read almost like a checklist of what ME/CFS patients need most. The cold redistributes blood centrally, stimulating autonomic recalibration and improving the sympatho-vagal balance. It transiently activates the HPA axis — releasing ACTH, cortisol, and beta-endorphins — in what can be described as a hormetic stimulus: a small, controlled stress that trains the body’s adaptive machinery. Inflammatory markers such as IL-6 and TNF-α decrease, oxidative stress is attenuated, pain conduction slows, and muscle recovery accelerates.
What the research actually shows
The most rigorous clinical evidence to date about cryotherapy support for chronic fatigue comes from a research group at Nicolaus Copernicus University in Toruń, Poland, led by Kujawski and Zalewski, who designed a series of studies specifically in ME/CFS patients. Their protocol combined ten sessions of WBC with static stretching over twelve working days, with gradual exposure increasing from 30 to 150 seconds per session.
The results, tracked from the intervention itself through to four weeks post-treatment, were consistent and clinically meaningful across three validated fatigue scales. But what stood out equally was what happened to cognition.
77%
of patients maintained fatigue improvements at 4-week follow-up (Chalder Fatigue Scale)
−22%
reduction in cognitive processing time on Trail Making Test A — patients surpassed healthy controls
10 sessions
over 12 working days · gradual exposure · full medical supervision throughout
On the Trail Making Test — a measure of visual scanning speed and executive flexibility — ME/CFS patients after the intervention actually outperformed the healthy control group at baseline. Cognitive improvements not only held at one month but continued to deepen, suggesting that the mechanism is not a transient analgesic effect but something more systemic: a genuine recalibration of autonomic function and a reduction in cerebral oxidative stress.
A longevity lens on chronic dysregulation
Here is where ME/CFS stops being a niche clinical topic and becomes a broader conversation. The biological profile of ME/CFS — low-grade inflammation, autonomic dysfunction, oxidative stress, vascular stiffness, and cognitive decline — overlaps substantially with the hallmarks of accelerated biological aging. The two conditions are not the same, but they share a common language of systemic dysregulation.
This is why WBC sits comfortably within a longevity medicine framework. Hormetic interventions — those that deliver a controlled, sub-maximal stress to activate adaptive pathways — are among the most evidence-supported strategies for modulating the biology of aging. Cold exposure, intermittent fasting, exercise, and hypoxic conditioning all operate through similar principles.
The particular advantage of WBC in ME/CFS is that it requires no sustained muscular contraction and appears to generate adaptive responses without triggering post-exertional malaise — the cardinal and often debilitating symptom that makes aerobic exercise a double-edged sword for these patients.
Clinical note: WBC is not appropriate for everyone. Medical screening prior to use is non-negotiable, with contraindications including uncontrolled hypertension, active arrhythmias, Raynaud’s phenomenon, cold allergy, acute infections, fever, pregnancy, and severe claustrophobia. Professional supervision throughout the protocol is essential.
The bigger picture
Whole-body cryotherapy will not replace comprehensive ME/CFS management — nor should it. But as one component of a multimodal protocol that includes precision nutrition, restorative sleep strategies, stress regulation, adapted movement, and clinical monitoring, it offers something genuinely rare: a physiologically coherent intervention that addresses multiple axes of dysregulation simultaneously, is well tolerated, and shows effects that persist and consolidate over time.
In a field that has long struggled to offer ME/CFS patients anything more than pacing and symptomatic management, that is not a small thing. And for longevity medicine, it is a reminder that some of the most powerful tools we have are the ones that work with the body’s own adaptive intelligence — rather than around it.
References
Kujawski S et al. Changes in the Allostatic Response to WBC and Static-Stretching in CFS Patients vs. Healthy Individuals. J Clin Med. 2021;10(13):2795. (1)
Kujawski S et al. Combination of WBC with static stretching reduces fatigue and improves autonomic nervous system function in CFS. J Transl Med. 2022;20:273.(2)
Kujawski S, Zalewski P et al. Effects of WBC and static stretching are maintained 4 weeks after treatment in most CFS patients. Cryobiology. 2023;112:104546. (
Shevchuk NA. Possible use of repeated cold stress for reducing fatigue in CFS: a hypothesis. Behav Brain Funct. 2007;3:55.
Leone R et al. The Perspective of WBC in Rheumatic Diseases: A Narrative Review. J Phys Med Rehabil Disabil. 2024;10:088.
